CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in SMMT — Summit Therapeutics Inc.
CIK 884546
SAN FRANCISCO, CA
Position in SMMT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$14,232,719
-$3,985,319 QoQ
Shares Held
976,851
+1.7% QoQ
Ownership
0.122%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#25
of 242 holders
Holding Since
Jun 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SMMT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,402,603,842 across 299 Biotechnology names. SMMT ranks #90 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in SMMT
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,232,719 | 976,851 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $18,218,038 | 960,867 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $15,612,081 | 892,629 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $18,106,217 | 876,390 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $27,486,758 | 1,291,671 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $28,177,230 | 1,460,717 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $26,501,109 | 1,485,072 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $31,376,414 | 1,432,713 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $7,290,886 | 934,729 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $4,208,496 | 1,016,545 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $2,489,538 | 953,846 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $1,759,288 | 940,796 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $780,785 | 311,070 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $25,516 | 14,581 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $64,226 | 15,112 | Shares | Sole | 2023-02-13 | |
| 2022-03-31 | $150,216 | 61,313 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $148,038 | 55,033 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $275,715 | 55,033 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $355,454 | 47,648 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||